Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07203326 · ClinicalTrials.gov registry record · Phase 4
Microderm for Root Coverage Procedures
A Phase 4 study of Connective Tissue Graft and Gum Recession, sponsored by Ohio State University.
- Active
- Registry status
- Phase 4
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT07203326 is a Phase 4 study of Connective Tissue Graft and Gum Recession that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 20 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07203326, a Phase 4 study of Connective Tissue Graft and Gum Recession, is active but no longer recruiting, sponsored by Ohio State University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This randomized pilot study will compare Acellular Dermal Matrix (ADM) and a microsurfaced Acellular Dermal Matrix (mADM) for wound healing, root coverage, gum tissue coverage of the surgical site, blood flow to the site, and patient comfort.
Conditions Studied
Interventions
- BIOLOGICAL Alloderm
- BIOLOGICAL MicroDerm
Study Locations (1)
Ohio
- The Ohio State University College of Dentistry - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2026-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07203326
The ClinicalTrials.gov registry entry for NCT07203326 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University, which has 552 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Connective Tissue Graft appearing as the primary indexed condition, and to 2 interventions - of which Alloderm is the first listed.
NCT07203326 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT07203326 about?
NCT07203326 is a clinical study titled "Microderm for Root Coverage Procedures". This randomized pilot study will compare Acellular Dermal Matrix (ADM) and a microsurfaced Acellular Dermal Matrix (mADM) for wound healing, root coverage, gum tissue coverage of the surgical site, blood flow to the site, and patient comfort.
What is the current status of trial NCT07203326?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 20 participants. The study started on 2025-02-13. Estimated completion is 2026-12.
What conditions does trial NCT07203326 study?
This clinical trial studies the following conditions: Connective Tissue Graft, Gum Recession.
What interventions are being tested in trial NCT07203326?
The interventions under investigation include: Alloderm (BIOLOGICAL), MicroDerm (BIOLOGICAL).
Who is sponsoring clinical trial NCT07203326?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07203326 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.